CRISPR/Cas9 for Human Genome Engineering and Disease Research

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 9 (Cas9) system is a powerful RNA-guided DNA targeting platform.
• It has significantly advanced biological research and therapeutic development by enabling precise genome modification.

Purpose of the Study:

• To review the current development and applications of CRISPR/Cas9 technologies.
• To highlight its use in gene editing, transcription regulation, genome imaging, and epigenetic modification.
• To discuss its role in functional genomics, genetic screening, and therapeutic strategies.

Main Methods:

• Review of existing literature on CRISPR/Cas9 system development and applications.
• Analysis of CRISPR/Cas9's utility in gene editing, transcriptional regulation, and epigenetic modifications.
• Exploration of its use in functional genomics, including genome-wide genetic screening.

Main Results:

• CRISPR/Cas9 technology has diverse applications in modifying, manipulating, and visualizing the human genome.
• The system is crucial for advancing functional genomics studies and developing novel therapeutic interventions.
• Applications include establishing disease models, correcting genetic mutations, and treating diseases.

Conclusions:

• The CRISPR/Cas9 system is a versatile platform revolutionizing biological research and therapeutics.
• Its broad applications in gene editing and beyond offer significant potential for future scientific and medical advancements.